• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清甲胎蛋白与 MAGE-A3 特异性细胞毒性 T 淋巴细胞联合检测在肝癌诊断中的应用。

Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma.

出版信息

Dis Markers. 2013;35(6):915-23. doi: 10.1155/2013/907394.

DOI:10.1155/2013/907394
PMID:24427779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3881391/
Abstract

We investigated the feasibility of the combined detection of HLA-A2/MAGE-A3 epitope-specific cytotoxic T lymphocytes (CTLs) and serum alpha-fetoprotein (AFP) for specific diagnosis of hepatocellular carcinoma (HCC). We detected the frequency of MAGE-A3 epitopes (p112-120, KVAELVHFL) in spontaneous CTLs in the peripheral blood of HCC patients, liver cirrhosis patients, and healthy subjects with HLA-A2/polypeptide complex (pentamer) detection technology. Eighty-five HCC cases, 38 liver cirrhosis cases, and 50 healthy cases who were HLA-A2-positive were selected from 175 HCC patients, 80 patients with liver cirrhosis, and 105 healthy volunteers, respectively. The frequency of HLA-A2-specific MAGE-A3(+) CTLs in the HCC group was significantly higher than that in the other groups. Combined detection of MAGE-A3(+) CTL frequency and serum AFP value had a higher specificity than either of the two indicators alone. The pentamer technique is helpful in distinguishing benign lesions and malignant lesions in the liver. Combined with serum AFP, it can improve the diagnosis performance for HCC, especially for AFP-negative cancer.

摘要

我们研究了联合检测 HLA-A2/MAGE-A3 表位特异性细胞毒性 T 淋巴细胞(CTL)和血清甲胎蛋白(AFP)对肝细胞癌(HCC)的特异性诊断的可行性。我们使用 HLA-A2/多肽复合物(五聚体)检测技术检测了 HCC 患者、肝硬化患者和健康受试者外周血中自发 CTL 中 MAGE-A3 表位(p112-120,KVAELVHFL)的频率。从 175 例 HCC 患者、80 例肝硬化患者和 105 例健康志愿者中分别选择了 85 例 HCC 病例、38 例肝硬化病例和 50 例健康对照,这些病例均为 HLA-A2 阳性。HCC 组中 HLA-A2 特异性 MAGE-A3(+)CTL 的频率明显高于其他组。联合检测 MAGE-A3(+)CTL 频率和血清 AFP 值的特异性高于任一单一指标。五聚体技术有助于区分肝脏的良性病变和恶性病变。与血清 AFP 联合使用,可以提高 HCC 的诊断性能,特别是对 AFP 阴性的癌症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954e/3881391/418a330a354b/DM35-06-907394.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954e/3881391/5580ec074652/DM35-06-907394.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954e/3881391/b8539b057535/DM35-06-907394.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954e/3881391/418a330a354b/DM35-06-907394.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954e/3881391/5580ec074652/DM35-06-907394.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954e/3881391/b8539b057535/DM35-06-907394.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954e/3881391/418a330a354b/DM35-06-907394.003.jpg

相似文献

1
Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma.血清甲胎蛋白与 MAGE-A3 特异性细胞毒性 T 淋巴细胞联合检测在肝癌诊断中的应用。
Dis Markers. 2013;35(6):915-23. doi: 10.1155/2013/907394.
2
The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma.血清组织多肽特异性抗原在肝细胞癌诊断中的价值。
Cancer. 1999 Mar 1;85(5):1039-43.
3
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.甲胎蛋白异质体 3 和异常凝血酶原在总甲胎蛋白指导下对肝细胞癌的诊断价值。
World J Gastroenterol. 2013 Jan 21;19(3):339-46. doi: 10.3748/wjg.v19.i3.339.
4
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.豆凝集素反应性甲胎蛋白在肝细胞癌诊断中的效用:在美国转诊人群中的评估
Clin Gastroenterol Hepatol. 2007 Mar;5(3):394-402; quiz 267. doi: 10.1016/j.cgh.2006.12.005.
5
Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.甲胎蛋白和 HCCR-1 单独或联合用于慢性肝炎、肝硬化和肝细胞癌患者的临床实用性。
Dis Markers. 2011;30(6):307-15. doi: 10.3233/DMA-2011-0789.
6
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.膜联蛋白 A2 是早期肝细胞癌有鉴别意义的血清学候选标志物。
Carcinogenesis. 2013 Mar;34(3):595-604. doi: 10.1093/carcin/bgs372. Epub 2012 Nov 27.
7
[Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].[肝细胞癌患者外周血中MAGE-1mRNA和AFP mRNA的围手术期检测:与复发的关系]
Zhonghua Yi Xue Za Zhi. 2005 Mar 9;85(9):595-8.
8
Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.评估膜联蛋白A2作为肝细胞癌潜在生物标志物的情况。 (原英文文本表述有误,正确的应该是“Evaluation of annexin A2 and [具体另一物质] as potential biomarkers for hepatocellular carcinoma.” 这里根据字面意思翻译,推测文本可能不完整)
Tumour Biol. 2016 Jan;37(1):211-6. doi: 10.1007/s13277-015-3524-x. Epub 2015 Jul 20.
9
Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma.在HLA - A24 + 肝细胞癌患者中识别细胞毒性T淋巴细胞识别的甲胎蛋白衍生肽。
Int J Cancer. 2006 Mar 1;118(5):1194-204. doi: 10.1002/ijc.21468.
10
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?肝细胞癌患者外周血中黑色素瘤抗原-1 mRNA与甲胎蛋白mRNA水平联合检测:术后复发或转移的预测指标?
ANZ J Surg. 2009 Jan-Feb;79(1-2):62-9. doi: 10.1111/j.1445-2197.2008.04801.x.

引用本文的文献

1
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.腹部超声和甲胎蛋白检测用于诊断慢性肝病成人的肝细胞癌。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013346. doi: 10.1002/14651858.CD013346.pub2.
2
LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells.LINC01234/微小RNA-31-5p/MAGEA3轴介导肝癌细胞的增殖和化疗耐药性。
Mol Ther Nucleic Acids. 2020 Mar 6;19:168-178. doi: 10.1016/j.omtn.2019.10.035. Epub 2019 Nov 13.
3
Serum levels of anti-sperm-associated antigen 9 antibody are elevated in patients with hepatocellular carcinoma.

本文引用的文献

1
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
2
TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.TCR基因转移:MAGE-C2/HLA-A2和MAGE-A3/HLA-DP4表位作为黑色素瘤特异性免疫靶点。
Clin Dev Immunol. 2012;2012:586314. doi: 10.1155/2012/586314. Epub 2012 Feb 12.
3
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.鉴定 MAGE-C1(CT-7)表位用于多发性骨髓瘤的 T 细胞治疗。
肝细胞癌患者血清中抗精子相关抗原9抗体水平升高。
Oncol Lett. 2017 Dec;14(6):7608-7614. doi: 10.3892/ol.2017.7152. Epub 2017 Oct 9.
4
Combination of acoustic radiation force impulse imaging, serological indexes and contrast-enhanced ultrasound for diagnosis of liver lesions.声辐射力脉冲成像、血清学指标与超声造影联合用于肝脏病变的诊断。
World J Gastroenterol. 2017 Aug 14;23(30):5602-5609. doi: 10.3748/wjg.v23.i30.5602.
5
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients.膜联蛋白A2作为埃及患者肝细胞癌的生物标志物。
World J Hepatol. 2017 Mar 28;9(9):469-476. doi: 10.4254/wjh.v9.i9.469.
6
Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.联合癌睾丸抗原提高了肝细胞癌患者预后的预测准确性。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3513-28. eCollection 2015.
Cancer Immunol Immunother. 2011 Jul;60(7):985-97. doi: 10.1007/s00262-011-1009-3. Epub 2011 Apr 3.
4
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL.在甲胎蛋白<20ng/mL 的肝细胞癌患者中,高度敏感的扁豆凝集素反应性甲胎蛋白的临床实用性。
Cancer Sci. 2011 May;102(5):1025-31. doi: 10.1111/j.1349-7006.2011.01875.x. Epub 2011 Feb 28.
5
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.一种靶向 HLA-A*0201 限制性表位的 TCR 可识别多种癌症中 MAGE-A 抗原超家族的多个表位。
J Immunol. 2011 Jan 15;186(2):685-96. doi: 10.4049/jimmunol.1001775. Epub 2010 Dec 13.
6
Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.肿瘤大小作为切除的小肝细胞癌的预后因素:争议再探讨。
J Gastroenterol Hepatol. 2011 May;26(5):851-7. doi: 10.1111/j.1440-1746.2010.06595.x.
7
Similar liver transplantation survival with selected cardiac death donors and brain death donors.在选择的心脏死亡供体和脑死亡供体中,肝移植的存活率相似。
Br J Surg. 2010 May;97(5):744-53. doi: 10.1002/bjs.7043.
8
Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.乙型肝炎相关肝细胞癌:流行病学特征与疾病负担
J Viral Hepat. 2009 Jul;16(7):453-63. doi: 10.1111/j.1365-2893.2009.01117.x. Epub 2009 Mar 17.
9
Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature.原发性和转移性肝肿瘤的射频消融:文献综述
Am J Surg. 2008 Apr;195(4):508-20. doi: 10.1016/j.amjsurg.2007.06.024.
10
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.人淋巴细胞中鼠-人杂交T细胞受体(TCR)抗肿瘤活性增强与配对改善及TCR/CD3稳定性提高有关。
Cancer Res. 2006 Sep 1;66(17):8878-86. doi: 10.1158/0008-5472.CAN-06-1450.